Hearing Loss and Tinnitus May Be Linked to COVID Vaccination
A new study published in the journal JAMA Otolaryngology-Head & Neck Surgery published on Feb. 24, 2022 has found a possible association between Pfizer/BioNTech’s BNT162b2 (also known as “Comirnaty”) messenger RNA (mRNA) COVID-19 biologic and sudden sensorineural hearing loss (SSNHL). The retrospective cohort study of 2 ,602, 557 patients in Israel suggested a slight increased risk of SSNHL.1 […]
COVID Vaccine-Induced Myocarditis Cited by Medical Examiners in Death of Two Boys
Two adolescent boys, who suddenly passed away in Connecticut and Michigan within a week after receiving the second dose of Pfizer/BioNTech’s BNT162b2 (also known as “Comirnaty”) messenger RNA (mRNA) COVID-19 vaccine, died due to myocarditis, according to a study published in the journal Archives of Pathology & Laboratory Medicine on Feb. 14 2022.1 The boys, […]
U.S. Hospitals May ‘Recalculate’ How They Report COVID Cases
Perhaps influenced by the lifting of COVID-19-related restrictions by several European countries—starting with Denmark—during the past two weeks, the United States seems to be on the verge of following Europe’s lead in declaring the pandemic over. In a recent interview with the Financial Times, White House chief medical advisor and director of the National Institute […]
Myocarditis Risk Following mRNA COVID Shots May Be Far Higher Than Previously Estimated
A new study conducted by researchers from the U.S. Centers for Disease Control and Prevention (CDC) and several universities and hospitals in the United States shows that the risk of myocarditis (inflammation of the heart muscle) after receiving a messenger RNA (mRNA) COVID-19 biologic is 133 times greater than the normal risk for the condition […]
Study Finds SARS-CoV-2 Much Less Infectious After 20 Minutes in Air
A new study conducted by the University of Bristol Aerosol Research Centre in the United Kingdom found that the SARS-CoV-2 virus loses 90 percent of its virulence within 20 minutes after being exhaled into the air. Further, researchers concluded that the virus loses 50 percent of its ability to spread after only 10 minutes of […]
Novavax’s Protein COVID-19 Vaccine Now Available in Europe
Novavax’s experimental NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine has been authorized for distribution in the European Union (E.U.), making it the fifth COVID vaccine available for use in the E.U. Approved for people over 18 years old, Nuvaxoid is the first protein subunit COVID vaccine to be approved for use.1 2 The […]